concept

TAUOPATHY

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about TAUOPATHY: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1556Connections
1Hypotheses
3Analyses
50Outgoing
50Incoming
0Experiments
3Debates

Summary

TAUOPATHY is a concept in neurodegeneration research. Key relationships include: activates, associated with, inhibits. Associated with ALS, Aging, Als. Connected to 436 entities in the SciDEX knowledge graph.

View on Wiki →

No AI portrait yet

💡 Concept Info
NameTAUOPATHY
Key Genes/ProteinsABCA1, ACHE, Actin, ADNP, AGING, AKT
Related DiseasesAging, Als, ALS, Alzheimer
Related PathwaysAkt, Alpha-Synuclein

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

Melatonin for Tauopathy: Comprehensive Evidence Synthesis

therapeutic · 4539 words

Pathway Diagram

graph TD
    TAUOPATHY["TAUOPATHY"]
    TAUOPATHY -->|"causes"| lipid_droplets["lipid droplets"]
    TAUOPATHY -->|"activates"| ALS["ALS"]
    TAUOPATHY -->|"activates"| Neurodegeneration["Neurodegeneration"]
    TAUOPATHY -->|"activates"| Alzheimer["Alzheimer"]
    TAUOPATHY -->|"activates"| Tauopathy["Tauopathy"]
    TAUOPATHY -->|"expressed in"| Aging["Aging"]
    TAUOPATHY -->|"expressed in"| Dementia["Dementia"]
    JUN["JUN"] -->|"target for"| TAUOPATHY
    APOE["APOE"] -->|"activates"| TAUOPATHY
    ABCA1["ABCA1"] -->|"target for"| TAUOPATHY
    RAB7A["RAB7A"] -->|"activates"| TAUOPATHY
    CHMP6["CHMP6"] -->|"activates"| TAUOPATHY
    RAB35["RAB35"] -->|"activates"| TAUOPATHY
    BMAL1["BMAL1"] -->|"inhibits"| TAUOPATHY
    BAG3["BAG3"] -->|"activates"| TAUOPATHY
    CLOCK["CLOCK"] -->|"activates"| TAUOPATHY
    TYROBP["TYROBP"] -->|"expressed in"| TAUOPATHY

Outgoing (662)

TargetRelationTypeStr
Tauopathyactivatesdisease1.00
Alzheimerassociated_withdisease1.00
Alzheimeractivatesdisease1.00
Tauopathyassociated_withdisease1.00
Neurodegenerationactivatesdisease1.00

Incoming (894)

SourceRelationTypeStr
NEURODEGENERATIVE DISEASESactivatesgene1.00
NEURODEGENERATIONactivatesgene1.00
TAUactivatesgene1.00
MICROGLIAactivatesgene1.00
TAUOPATHYactivatesgene1.00

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
TREM2 Antagonism in Late-Stage Tauopathy — Reducing Neuroinf 0.628 Alzheimer's disease TREM2 agonism vs antagonism in DAM micro

Mentioning Analyses (3)

Scientific analyses that reference this entity

Do tau-containing vesicles exhibit unique surface glycosylation patterns that di

neurodegeneration | 2026-04-09 | 0 hypotheses

What are the minimal structural requirements for HSP70/HSP90 inhibitors to achie

drug discovery | 2026-04-09 | 0 hypotheses

What determines the specificity of DDR protein recruitment to dilncRNA-induced c

neurodegeneration | 2026-04-08 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (12)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
The gain-of-function TREM2-T96K mutation increases risk for Alzheimer's disease [PMID:41109213] Pilat DJ, Le H, Prokopenko D, Lin CJ, Ei Neuron 2026 0
Role of TREM2 in neuroinflammation. [PMID:41213496] Abdulkhaliq AA, Alasiri G, Almoghrabi Y, Exp Neurol 2026 0
Synergistic potential of TREM2 agonists and exercise training in Alzheimer's dis [PMID:41494649] Zhang J, St Pierre Schneider B, Muguerza Am J Physiol Endocrinol Metab 2026 0
Armored macrophage-targeted CAR-T cells reset and reprogram the tumor microenvir [PMID:41576929] Mateus-Tique J, Lakshmi A, Singh B, Iyer Cancer Cell 2026 0
Peripheral cancer attenuates amyloid pathology in Alzheimer's disease via cystat [PMID:41576952] Li X, Tang X, Zeng J, Duan L, Hou Z et a Cell 2026 0
TREM2 expression level is critical for microglial state, metabolic capacity and [PMID:41580393] Feiten AF, Dahm K, Schlepckow K, van Len Nat Commun 2026 0
Large-scale single-cell analysis and in silico perturbation reveal dynamic evolu [PMID:41617928] Xia P, Shuang S, Fu D, Liu L, Yang D et NPJ Precis Oncol 2026 0
Dissecting genetic and immune drivers of heterogeneous responses to neoadjuvant [PMID:41720086] Zhao Q, Huang R, Wang C, Hu J, Nie R et Cancer Cell 2026 0
TREM2 in neurodegeneration and diseases. [PMID:41792456] ["Abdulkhaliq A", "Alasiri G", "Kim B", Molecular psychiatry 2026 0
Alzheimer's Disease as a Disorder of Neuroimmune Dysregulation. [PMID:41745721] Aranda-Abreu GE, Rojas-Durán F, Hernánde Neurology international 2026 0
Molecular mechanism of Alzheimer's disease using integrated multi-omics. [PMID:41907842] Alhusaini M, Mussa BM, Ilce BY, Alhaj H, Frontiers in aging neuroscienc 2026 0
Viral and non-viral cellular therapies for neurodegeneration. [PMID:41585268] ["Srivastav Jyotsna", "Sharma Sachin"] Frontiers in medicine 2025 0

Debates (3)

Multi-agent debates referencing this entity

While the study shows 53BP1 forms phase-separated foci driven by dilncRNAs, it's

closed · Rounds: 7 · Score: 0.95 · 2026-04-10

What are the minimal structural requirements for HSP70/HSP90 inhibitors to achie

closed · Rounds: 4 · Score: 0.86 · 2026-04-10

Do tau-containing vesicles exhibit unique surface glycosylation patterns that di

closed · Rounds: 4 · Score: 0.95 · 2026-04-10

Related Research

Hypotheses and analyses mentioning TAUOPATHY in their description or question text

No additional research found